Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Avari

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
London Journal of Primary Care|May 26, 2017
Human immunodeficiency virus and type 2 diabetesP Avari, S Devendra
Diabetic Medicine : a Journal of the British Diabetic Association|February 26, 2019
Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non-invasive or invasive)?P Avari, M Reddy, N Oliver
British Journal of Hospital Medicine (London, England : 2005)|March 13, 2018
Addisonian crisis: assessment and managementC Feeney, K G Buell, P Avari, et al.
JRSM Cardiovascular Disease|October 21, 2017
Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patientsK S Rathod, S Antoniou, P Avari, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
London Journal of Primary Care|May 26, 2017
Human immunodeficiency virus and type 2 diabetesP Avari, S Devendra
Diabetic Medicine : a Journal of the British Diabetic Association|February 26, 2019
Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non-invasive or invasive)?P Avari, M Reddy, N Oliver
British Journal of Hospital Medicine (London, England : 2005)|March 13, 2018
Addisonian crisis: assessment and managementC Feeney, K G Buell, P Avari, et al.
JRSM Cardiovascular Disease|October 21, 2017
Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patientsK S Rathod, S Antoniou, P Avari, et al.
Pageof 1